$2.0B
Thrive Capital is set to lead the financing round, which would value the artificial intelligence drug discovery startup at more than triple its previous raise.
Isomorphic Labs
Isomorphic Labs builds computational systems for protein prediction and molecular modelling to accelerate drug discovery.
$2.5BTotal raised
London-based drug discovery startup spun out from Google DeepMind, developing artificial intelligence systems for molecular modelling and pharmaceutical research.
Founders
SD
Sir Demis Hassabis
Founder and CEO
Investors
- $2.0B
- £459M
Funding history
£459M
The financing round was led by Thrive Capital with backing from GV and Alphabet.